Cost of disorders of the brain in Europe 2010

European Neuropsychopharmacology - Tập 21 Số 10 - Trang 718-779 - 2011
Anders Gustavsson1, Mikael Svensson2, Frank Jacobi3, Christer Allgulander4, Jordi Alonso5, Ettore Beghi6, Richard Dodel7, Mattias Ekman1, Carlo Faravelli8, Laura Fratiglioni9, Brenda Gannon10, David Hilton Jones11, Poul Jennum12, Albena Jordanova13, Linus Jönsson1, Korinna Karampampa1, Martín Knapp14,15, Gisela Kobelt16, Tobias Kurth17, Roselind Lieb18, Mattias Linde19, Christina Ljungcrantz1, And re as Maercker20, Beatrice Melin21, Massimo Moscarelli22, Amir Musayev1, Fiona Norwood23, Martin Preisig24, Maura Pugliatti25, Juergen Rehm26, Luis Salvador‐Carulla27, Brigitte Schlehofer28, Roland Simon29, Hans‐Christoph Steinhausen30, Lars Jacob Stovner31, Jean‐Michel Vallat32, Peter Van den Bergh33, Jim van Os34,35, Weili Xu9, Hans‐Ulrich Wïttchen3, B Jönsson36, Jes Olesen37
1OptumInsight, Stockholm, Sweden
2Department of Economics and Statistics , Karlstad University , Sweden
3Institute of Clinical Psychology and Psychotherapy, Centre of Epidemiology and Longitudinal Studies (CELOS), Technische Universität Dresden, Dresden, Germany
4Department of Clinical Neuroscience, Karolinska University Hospital Huddinge, Sweden.
5Health Services Research Unit (IMIM‐Hospital del Mar), Barcelona, Spain,
6Laboratorio Malattie Neurologiche, Istituto “Mario Negri”, Milano, Italy
7Department of Neurology Marburg, Philips University Marburg, Germany
8Department of Psychology, Florence University, Italy
9Aging Research Centre, Karolinska Institute, Stockholm, Sweden
10Academic Unit of Health Economics, Leeds Institute of Health Sciences, Leeds, UK
11Department of Clinical Neurology, John Radcliffe Hospital, Oxford, UK
12Centre for Sleep Medicine, Glosptup Hospital, Copenhagen, Denmark
13Department of Molecular Genetics, VIB, Antwerpen, Belgium
14Centre for the Economics of Mental Health at the Institute of Psychiatry, King's College London, UK
15Personal Social Services Research Unit, London School of Economics, UK
16Lund Univ., Sweden#TAB#
17Department of Epidemiology, Harvard School of Public Health, USA.
18Department of Psychology, University of Basel, Switzerland
19Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway
20Department of Psychology, University of Zürich, Switzerland
21Department of Oncology, University of Umeå, Umeå, Sweden
22International Centre of Mental Health Policy and Economics, Milan, Italy
23Department of Neurology, King’s College Hospital, London, UK
24Department of Psychiatry, University Hospital Centre and University of Lausanne, Switzerland
25Department of Neurosciences, University of Sassari, Italy
26Technische Universitat Dresden, Germany#TAB#
27Asociación Científica PSICOST, Jerez de la Frontera, Spain
28German Cancer Research Centre, Heidelberg, Germany
29European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal
30Aalborg Psychiatric Hospital, Denmark
31Norwegian National Headache Centre, Department of Neuroscience, Norwegian University of Science and Technology (NTNU) and St. Olavs Hospital, Trondheim, Norway
32Centre national de référence neuropathies périphériques rares, Department of Neurology, University Hospital, Limoges, France
33Centre de Référence Neuromusculaire, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium
34Department of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, Maastricht, The Netherlands
35Division of Psychological Medicine, Institute of Psychiatry, King's College London, London, UK
36Stockholm School of Economics, Stockholm, Sweden
37Danish Headache Centre at the Department of Neurology, Glostrup University Hospital, Denmark

Tóm tắt

Từ khóa


Tài liệu tham khảo

Abela, 2007, Estimated prevalance of dementia in the Maltese Islands, Malta Med. J., 19, 23

Abu-Baker, 2007, Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies, Biochim. Biophys. Acta, 1772, 173, 10.1016/j.bbadis.2006.10.003

Acarturk, 2009, Economic costs of social phobia: a population-based study, J. Affect. Disord., 115, 421, 10.1016/j.jad.2008.10.008

AccessEconomics, 2007

Adelow, 2009, Newly diagnosed single unprovoked seizures and epilepsy in Stockholm, Sweden: first report from the Stockholm Incidence Registry of Epilepsy (SIRE), Epilepsia, 50, 1094, 10.1111/j.1528-1167.2008.01726.x

af Geijerstam, 2003, Mild head injury — mortality and complication rate: meta-analysis of findings in a systematic literature review, Acta Neurochir. (Wien.), 145, 843, 10.1007/s00701-003-0115-1

Ancoli-Israel, 1989, Epidemiology of sleep disorders, Clin. Geriatr. Med., 5, 347, 10.1016/S0749-0690(18)30683-9

Ancoli-Israel, 1995, Sleep-disordered breathing in African–American elderly, Am. J. Respir. Crit. Care Med., 152, 1946, 10.1164/ajrccm.152.6.8520760

Andersen, 1997, Prevalence of very mild to severe dementia in Denmark, Acta Neurol. Scand., 96, 82, 10.1111/j.1600-0404.1997.tb00244.x

Andlin-Sobocki, 2005, Cost of addiction in Europe, Eur. J. Neurol., 12, 28, 10.1111/j.1468-1331.2005.01194.x

Andlin-Sobocki, 2005, Cost of psychotic disorders in Europe, Eur. J. Neurol., 12, 74, 10.1111/j.1468-1331.2005.01198.x

Andlin-Sobocki, 2005, Cost of affective disorders in Europe, Eur. J. Neurol., 12, 34, 10.1111/j.1468-1331.2005.01195.x

Andlin-Sobocki, 2005, Cost of anxiety disorders in Europe, Eur. J. Neurol., 12, 39, 10.1111/j.1468-1331.2005.01196.x

Andlin-Sobocki, 2005, Cost of disorders of the brain in Europe, Eur. J. Neurol., 12, 1, 10.1111/j.1468-1331.2005.01202.x

Andrée, C., Stovner, L., Steiner, T., et al., 2011. The Eurolight study on the impact and burden of primary headache in Europe — Description of the Methodology. Manuscript JHP.

Ares, 2007, Prevalence of multiple sclerosis in Santiago de Compostela (Galicia, Spain), Mult. Scler., 13, 262, 10.1177/1352458506069540

Atance Martinez, 2004, Costs study in Alzheimer's disease, Rev. Clin. Esp., 204, 64

Balakrishnan, 2009, The burden of alcohol-related ill health in the United Kingdom, J. Public Health (Oxf.), 31, 366, 10.1093/pubmed/fdp051

Balasa, 2007, The prevalence of multiple sclerosis in Mures County, Central Romania, Rev. Rom. Neurol., 6, 80

Baldwin, 2001, The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study, Sleep, 24, 96, 10.1093/sleep/24.1.96

Baldwin, 2010, Sleep disturbances, quality of life, and ethnicity: the Sleep Heart Health Study, J. Clin. Sleep Med., 6, 176, 10.5664/jcsm.27768

Banerjee, 2009, The descriptive epidemiology of epilepsy—a review, Epilepsy Res., 85, 31, 10.1016/j.eplepsyres.2009.03.003

Barth, 2005, Indirect costs in idiopathic Parkinson's disease, Fortschr. Neurol. Psychiatr., 73, 187, 10.1055/s-2004-830106

Batelaan, 2007, Economic costs of full-blown and subthreshold panic disorder, J. Affect. Disord., 104, 127, 10.1016/j.jad.2007.03.013

Baumgaertel, 1995, Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample, J. Am. Acad. Child Adolesc. Psychiatry, 34, 629, 10.1097/00004583-199505000-00015

Baumhackl, 2002, Prevalence of multiple sclerosis in Austria. Results of a nationwide survey, Neuroepidemiology, 21, 226, 10.1159/000065640

Bdzan, 2007, Prevalence of dementia in a rural population, Psychiatr. Pol., 41, 181

Bebbington, 2005, The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study, Soc. Psychiatry Psychiatr. Epidemiol., 40, 707, 10.1007/s00127-005-0955-5

Beesdo, 2009, Mood episodes and mood disorders: patterns of incidence and conversion in the first three decades of life, Bipolar. Disord., 11, 637, 10.1111/j.1399-5618.2009.00738.x

Beesdo, 2010, Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder, Arch. Gen. Psychiatry, 67, 47, 10.1001/archgenpsychiatry.2009.177

Beghi, 1991, Antiepileptic drugs as ‘tracers’ of disease. A calculation of the prevalence of epilepsy through an analysis of drug consumption. The Group for the Study of Epilepsy in General Practice, Neuroepidemiology, 10, 33, 10.1159/000110245

Beghi, 2004, Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS), Epilepsia, 45, 171, 10.1111/j.0013-9580.2004.14103.x

Behan, 2008, The economic cost of schizophrenia in Ireland: a cost of illness study, Ir. J. Psych Med., 25, 80, 10.1017/S079096670001106X

Beilmann, 1999, Prevalence of childhood epilepsy in Estonia, Epilepsia, 40, 1011, 10.1111/j.1528-1157.1999.tb00811.x

Benavente, 2009, Prevalence of epilepsy amongst adolescents in Huesca, Spain: a community-based study, Eur. J. Neurol., 16, 1138, 10.1111/j.1468-1331.2009.02659.x

Bencsik, 1998, The prevalence of multiple sclerosis in the Hungarian city of Szeged, Acta Neurol. Scand., 97, 315, 10.1111/j.1600-0404.1998.tb05959.x

Benedikz, 2002, The natural history of untreated multiple sclerosis in Iceland. A total population-based 50year prospective study, Clin. Neurol. Neurosurg., 104, 208, 10.1016/S0303-8467(02)00040-9

Bentzen, 2010, Prevalence of multiple sclerosis in Denmark 1950–2005, Mult. Scler., 16, 520, 10.1177/1352458510364197

Berg, 2005, Cost of migraine and other headaches in Europe, Eur. J. Neurol., 12, 59, 10.1111/j.1468-1331.2005.01192.x

Berg, 2005, Cost of trauma in Europe, Eur. J. Neurol., 12, 85, 10.1111/j.1468-1331.2005.01200.x

Berg, 2006, Costs and quality of life of multiple sclerosis in Sweden, Eur. J. Health Econ., 7, S75, 10.1007/s10198-006-0379-5

Bertelli, 2009, New contributions of psychiatric research in the field of intellectual disabilities, Adv. Psychiatry, 3, 37

Berto, 2000, Cost-of-illness of epilepsy in Italy. Data from a multicentre observational study (Episcreen), PharmacoEconomics, 17, 197, 10.2165/00019053-200017020-00008

Bielen, 2007, Prevalence of epilepsy in Croatia: a population-based survey, Acta Neurol. Scand., 116, 361, 10.1111/j.1600-0404.2007.00881.x

Bixler, 1998, Effects of age on sleep apnea in men: I. Prevalence and severity, Am. J. Respir. Crit. Care Med., 157, 144, 10.1164/ajrccm.157.1.9706079

Bixler, 2000, Association of hypertension and sleep-disordered breathing, Arch. Intern. Med., 160, 2289, 10.1001/archinte.160.15.2289

Bixler, 2001, Prevalence of sleep-disordered breathing in women: effects of gender, Am. J. Respir. Crit. Care Med., 163, 608, 10.1164/ajrccm.163.3.9911064

Bixler, 2009, Sleep disordered breathing in children in a general population sample: prevalence and risk factors, Sleep, 32, 731, 10.1093/sleep/32.6.731

Bliwise, 1988, Sleep apnea and mortality in an aged cohort, Am. J. Public Health, 78, 544, 10.2105/AJPH.78.5.544

Blomqvist, 2000, Brain tumours in Sweden 1996: care and costs, J. Neurol. Neurosurg. Psychiatry, 69, 792, 10.1136/jnnp.69.6.792

Bluestein, 2010, Psychosocial correlates of insomnia severity in primary care, J. Am. Board Fam. Med., 23, 204, 10.3122/jabfm.2010.02.090179

Boada, 1999, Costs of health care resources of ambulatory-care patients diagnosed with Alzheimer's disease in Spain, Med. Clin. (Barc.), 113, 690

Bondy, 2008, Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium, Cancer, 113, 1953, 10.1002/cncr.23741

Börjesson-Hanson, 2004, The prevalence of dementia in 95year olds, Neurology, 63, 2436, 10.1212/01.WNL.0000147260.52841.27

Bostrom, 2009, High prevalence of multiple sclerosis in the Swedish county of Varmland, Mult. Scler., 15, 1253, 10.1177/1352458509345909

Boström, 2007, Patients with Lewy body dementia use more resources than those with Alzheimer's disease, Int. J. Geriatr. Psychiatry, 22, 713, 10.1002/gps.1738

Boyle, 2010, A cohort study of the prevalence of sleep problems in adults with intellectual disabilities, J. Sleep Res., 19, 42, 10.1111/j.1365-2869.2009.00788.x

Bray, 2002, Estimates of cancer incidence and mortality in Europe in 1995, Eur. J. Cancer, 38, 99, 10.1016/S0959-8049(01)00350-1

Brayne, 2006, Incidence of dementia in England and Wales: the MRC Cognitive Function and Ageing Study, Alzheimer Dis. Assoc. Disord., 20, S47, 10.1097/00002093-200607001-00006

Brodtkorb, 2008, Epilepsy prevalence by individual interview in a Norwegian community, Seizure, 17, 646, 10.1016/j.seizure.2008.03.005

Broman, 2008, Restless legs syndrome and its relationship with insomnia symptoms and daytime distress: epidemiological survey in Sweden, Psychiatry Clin. Neurosci., 62, 472, 10.1111/j.1440-1819.2008.01825.x

Brorson, 1970, Epilepsy among children and adolescents, 1

Brower, 2010, Prevalence and correlates of withdrawal-related insomnia among adults with alcohol dependence: results from a national survey, Am. J. Addict., 19, 238, 10.1111/j.1521-0391.2010.00035.x

Casado, 2006, Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability, BMC Health Serv. Res., 6, 143, 10.1186/1472-6963-6-143

Cassidy, 2004, WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury, J. Rehabil. Med., 28, 10.1080/16501960410023732

Cats, 2010, Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy, Neurology, 75, 818, 10.1212/WNL.0b013e3181f0738e

Cavallo, 1997, The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy, Alzheimer Dis. Assoc. Disord., 11, 184

Cavazzuti, 1980, Epidemiology of different types of epilepsy in school age children of Modena, Italy, Epilepsia, 21, 57, 10.1111/j.1528-1157.1980.tb04044.x

Chasens, 2010, Sleepiness and health in midlife women: results of the National Sleep Foundation's 2007 Sleep in America poll, Behav. Sleep Med., 8, 157, 10.1080/15402002.2010.487462

Chisholm, 2003, Depression status, medical comorbidity and resource costs. Evidence from an international study of major depression in primary care (LIDO), Br. J. Psychiatry, 183, 121, 10.1192/bjp.183.2.121

Christensen, 2007, Incidence and prevalence of epilepsy in Denmark, Epilepsy Res., 76, 60, 10.1016/j.eplepsyres.2007.06.012

Cockerell, 1994, The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies, Epilepsy Res., 18, 249, 10.1016/0920-1211(94)90045-0

Coduras, 2010, Prospective one-year cost-of-illness study in a cohort of patients with dementia of alzheimer's disease type in Spain: the ECO study, J. Alzheimers Dis., 19, 601, 10.3233/JAD-2010-1258

Coid, 2006, Prevalence and correlates of personality disorder in Great Britain, Br. J. Psychiatry, 188, 423, 10.1192/bjp.188.5.423

Coyle, 1997, Costing substance misuse services, Addiction, 92, 1007, 10.1111/j.1360-0443.1997.tb02980.x

Cubo, 2005, Burden of disease related to Parkinson's disease in Spain in the year 2000, Mov. Disord., 20, 1481, 10.1002/mds.20622

Cuijpers, 2007, Economic costs of minor depression: a population-based study, Acta Psychiatr. Scand., 115, 229, 10.1111/j.1600-0447.2006.00851.x

Cuijpers, 2010, Economic costs of neuroticism: a population-based study, Arch. Gen. Psychiatry, 67, 1086, 10.1001/archgenpsychiatry.2010.130

Das, 2002, Annual cost of bipolar disorder to UK society, Br. J. Psychiatry, 180, 227, 10.1192/bjp.180.3.227

Dauvilliers, 2001, Age at onset of narcolepsy in two large populations of patients in France and Quebec, Neurology, 57, 2029, 10.1212/WNL.57.11.2029

Dauvilliers, 2002, Severity of narcolepsy among French of different ethnic origins (south of France and Martinique), Sleep, 25, 50, 10.1093/sleep/25.1.50

de la Court, 1996, Prevalence of epilepsy in the elderly: the Rotterdam Study, Epilepsia, 37, 141, 10.1111/j.1528-1157.1996.tb00005.x

De Ronchi, 2005, Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy, Dement. Geriatr. Cogn. Disord., 19, 97, 10.1159/000082660

De Sä, 2006, The prevalence of multiple sclerosis in the District of Santarem, Portugal, J. Neurol., 253, 914, 10.1007/s00415-006-0132-0

De Zélicourt, 2000, The contributing factors to medical cost of epilepsy: an estimation based on a French prospective cohort study of patients with newly diagnosed epileptic seizures (the CAROLE study). Active coordination of the longitudinal observational network in epilepsy, Seizure, 9, 88, 10.1053/seiz.1999.0364

De Zélicourt, 2003, Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France, PharmacoEconomics, 21, 1081, 10.2165/00019053-200321150-00002

de Girolamo, 2006, Prevalence of common mental disorders in Italy: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD), Soc. Psychiatry Psychiatr. Epidemiol., 41, 853, 10.1007/s00127-006-0097-4

de Graaf, 2011, Prevalence of mental disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and incidence study-2, Soc. Psychiatry Psychiatr. Epidemiol.

Dean, 2002, Multiple sclerosis in Malta in 1999: an update, J. Neurol. Neurosurg. Psychiatry, 73, 256, 10.1136/jnnp.73.3.256

DeAngelis, 2001, Brain tumors, N. Engl. J. Med., 344, 114, 10.1056/NEJM200101113440207

Dengler, 2006, Prospective study of the direct and indirect costs of idiopathic Parkinson's disease, Nervenarzt, 77, 1204, 10.1007/s00115-006-2150-7

Dikmen, 1993, Psychosocial outcome in patients with moderate to severe head injury: 2-year follow-up, Brain Inj., 7, 113, 10.3109/02699059309008165

Dikmen, 1994, Employment following traumatic head injuries, Arch. Neurol., 51, 177, 10.1001/archneur.1994.00540140087018

Dikmen, 1995, One year psychosocial outcome in head injury, J. Int. Neuropsychol. Soc., 1, 67, 10.1017/S1355617700000126

Dodel, 1997, Cost of illness in Parkinson disease. A retrospective 3-month analysis of direct costs, Nervenarzt, 68, 978, 10.1007/s001150050226

Dodel, 1998, The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis, PharmacoEconomics, 14, 299, 10.2165/00019053-199814030-00006

Dominguez, 2011, Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study, Schizophr. Bull., 37, 84, 10.1093/schbul/sbp022

Döpfner, 2008, How often do children meet ICD-10/DSM-IV criteria of attention deficit/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample—results of the BELLA study, Eur. Child Adolesc. Psychiatry, 17, 59, 10.1007/s00787-008-1007-y

Dura-Trave, 2008, Incidence of epilepsies and epileptic syndromes among children in Navarre, Spain: 2002 through 2005, J. Child Neurol., 23, 878, 10.1177/0883073808314898

Durkin, 2002, The epidemiology of developmental disabilities in low-income countries, Ment. Retard. Dev. Disabil. Res. Rev., 8, 206, 10.1002/mrdd.10039

Edwards, 2005, Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6months, Lancet, 365, 1957, 10.1016/S0140-6736(05)66552-X

Ehret, 2009, Direct costs for Parkinson's treatment in private neurology practices in Berlin, Nervenarzt, 80, 452, 10.1007/s00115-009-2671-y

Endziniene, 1997, Prevalence of childhood epilepsy in Kaunas, Lithuania, Brain Dev., 19, 379, 10.1016/S0387-7604(97)00035-1

Engholm, 2010, NORDCAN—a Nordic tool for cancer information, planning, quality control and research, Acta Oncol., 49, 725, 10.3109/02841861003782017

Eriksson, 1997, Prevalence, classification, and severity of epilepsy and epileptic syndromes in children, Epilepsia, 38, 1275, 10.1111/j.1528-1157.1997.tb00064.x

Errea, 1999, Prevalence of Parkinson's disease in lower Aragon, Spain, Mov. Disord., 14, 596, 10.1002/1531-8257(199907)14:4<596::AID-MDS1008>3.0.CO;2-U

Espèrou, 2000, Cost analysis of plasma-exchange therapy for the treatment of Guillain–Barre syndrome. French Cooperative Group on plasma exchange in Guillain–Barre syndrome, Intensive Care Med., 26, 1094, 10.1007/s001340051323

Esser, 1990, Epidemiology and course of psychiatric disorders in school-age children—results of a longitudinal study, J. Child Psychol. Psychiatry, 31, 243, 10.1111/j.1469-7610.1990.tb01565.x

European Central Bank

European Commission, 2009, Brain Research EU Funding, 1

European Heart Network

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

European Network for Parkinson's Disease

Eurostat

Eurostat

Eurostat

Eurostat

Eurostat

Eurostat

Eurostat

Eurostat

Eurostat

Eurostat

Evers, 2004, International comparison of stroke cost studies, Stroke, 35, 1209, 10.1161/01.STR.0000125860.48180.48

Fasbender, 2008, Incidence of multiple sclerosis in the urban area of Erfurt, Thuringia, Germany, Neuroepidemiology, 30, 147, 10.1159/000122331

Fenoglio, 2003, The social cost of alcohol, tobacco and illicit drugs in France, 1997, Eur. Addict. Res., 9, 18, 10.1159/000067730

Ferini-Strambi, 1994, Snoring and nocturnal oxygen desaturations in an Italian middle-aged male population. Epidemiologic study with an ambulatory device, Chest, 105, 1759, 10.1378/chest.105.6.1759

Ferini-Strambi, 1999, Snoring & sleep apnea: a population study in Italian women, Sleep, 22, 859

Ferlay, 2010, Estimates of cancer incidence and mortality in Europe in 2008, Eur. J. Cancer, 46, 765, 10.1016/j.ejca.2009.12.014

Florescu, 2009, The Mental Health Study. Romania 2007. Prevalence, severity, and treatment of 12-month DSM-IV disorders, Manage. Health, 13, 23, 10.5233/mih.2009.0028

Fombonne, 2009, Epidemiology of pervasive developmental disorders, Pediatr. Res., 65, 591, 10.1203/PDR.0b013e31819e7203

Ford, 2003, The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders, J. Am. Acad. Child Adolesc. Psychiatry, 42, 1203, 10.1097/00004583-200310000-00011

Forsgren, 1992, Prevalence of epilepsy in adults in northern Sweden, Epilepsia, 33, 450, 10.1111/j.1528-1157.1992.tb01690.x

Forsgren, 2005, Cost of epilepsy in Europe, Eur. J. Neurol., 12, 54, 10.1111/j.1468-1331.2005.01191.x

Forsgren, 2005, The epidemiology of epilepsy in Europe — a systematic review, Eur. J. Neurol., 12, 245, 10.1111/j.1468-1331.2004.00992.x

Framework Programme 6

Francois, 2004, Cost effectiveness of memantine in moderately severe to severe Alzheimer's disease: a Markov model in Finland, Clin. Drug Investig., 24, 373, 10.2165/00044011-200424070-00001

Friemel, 2005, The direct costs of depressive disorders in Germany, Psychiatr. Prax., 32, 113, 10.1055/s-2004-834611

Fromont, 2010, Geographic variations of multiple sclerosis in France, Brain, 133, 1889, 10.1093/brain/awq134

Gallitto, 2005, Prevalence and characteristics of epilepsy in the Aeolian islands, Epilepsia, 46, 1828, 10.1111/j.1528-1167.2005.00278.x

Gao, 2008, The incidence rate of seizures in relation to BMI in UK adults, Obesity (Silver Spring), 16, 2126, 10.1038/oby.2008.310

Garattini, 2004, Direct costs of schizophrenia and related disorders in Italian community mental health services: a multicenter, prospective 1-year followup study, Schizophr. Bull., 30, 295, 10.1093/oxfordjournals.schbul.a007079

Garcia-Altes, 2002, The social cost of illegal drug consumption in Spain, Addiction, 97, 1145, 10.1046/j.1360-0443.2002.00170.x

Gascon-Bayarri, 2007, Prevalence of dementia subtypes in El Prat de Llobregat, Catalonia, Spain: the PRATICON study, Neuroepidemiology, 28, 224, 10.1159/000108597

Gerzeli, 2005, The economic burden of stroke in Italy. The EcLIPSE study: economic longitudinal incidence-based project for stroke evaluation, Neurol. Sci., 26, 72, 10.1007/s10072-005-0439-0

Gessner, 1993, The cost of epilepsy in Switzerland, Int. J. Health Sci., 4, 121

Gislason, 1988, Prevalence of sleep apnea syndrome among Swedish men—an epidemiological study, J. Clin. Epidemiol., 41, 571, 10.1016/0895-4356(88)90061-3

Giuliani, 1992, Epilepsy in an Italian community as assessed by a survey for prescriptions of antiepileptic drugs: epidemiology and patterns of care, Acta Neurol. Scand., 85, 23, 10.1111/j.1600-0404.1992.tb03991.x

Godet-Cayré, 2006, Insomnia and absenteeism at work. Who pays the cost?, Sleep, 29, 179, 10.1093/sleep/29.2.179

Godfrey, 2004, Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS), Addiction, 99, 697, 10.1111/j.1360-0443.2004.00752.x

Goldberg, 2005, The cost of migraine and its treatment, Am. J. Manag. Care., 11, S62

Gomez-Beneyto, 1994, Prevalence of mental disorders among children in Valencia, Spain, Acta Psychiatr. Scand., 89, 352, 10.1111/j.1600-0447.1994.tb01528.x

Gonzalez-Pinto, 2010, In-patient care costs of patients with bipolar I disorder: a comparison between two European centers, J. Affect. Disord., 121, 152, 10.1016/j.jad.2009.05.010

Gostynski, 2002, Prevalence of dementia in the city of Zurich, Soz. Praventivmed., 47, 330, 10.1007/PL00012643

Grabe, 2009, Association of mental distress with health care utilization and costs: a 5-year observation in a general population, Soc. Psychiatry Psychiatr. Epidemiol., 44, 835, 10.1007/s00127-009-0005-9

Granieri, 1983, A descriptive study of epilepsy in the district of Copparo, Italy, 1964–1978, Epilepsia, 24, 502, 10.1111/j.1528-1157.1983.tb04921.x

Granieri, 2007, Multiple sclerosis in the province of Ferrara: evidence for an increasing trend, J. Neurol., 254, 1642, 10.1007/s00415-007-0560-5

Gray, 2008, Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland, Mult. Scler., 14, 880, 10.1177/1352458508090663

Guerrini, 2001, The costs of childhood epilepsy in Italy: comparative findings from three health care settings, Epilepsia, 42, 641, 10.1046/j.1528-1157.2001.27300.x

Guglieri, 2008, Limb-girdle muscular dystrophies, Curr. Opin. Neurol., 21, 576, 10.1097/WCO.0b013e32830efdc2

Gustavsson, 2010, Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS study, J. Nutr. Health Aging, 14, 648, 10.1007/s12603-010-0311-7

Gustavsson, 2011, Predictors of costs of care in Alzheimer's disease: a multinational sample of 1222 patients, Alzheimers Dement., 7, 318, 10.1016/j.jalz.2010.09.001

Hagell, 2002, Resource use and costs in a Swedish cohort of patients with Parkinson's disease, Mov. Disord., 17, 1213, 10.1002/mds.10262

Hakkaart-van Roijen, 2004, The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands, Acta Psychiatr. Scand., 110, 383, 10.1111/j.1600-0447.2004.00403.x

Hakkaart-van, 2007, Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD), Eur. Child Adolesc. Psychiatry, 16, 316, 10.1007/s00787-007-0603-6

Halpin, 2006, Health economics of chronic obstructive pulmonary disease, Proc. Am. Thorac. Soc., 3, 227, 10.1513/pats.200507-072SF

Hamer, 2006, Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany, Epilepsia, 47, 2165, 10.1111/j.1528-1167.2006.00889.x

Hamre, 2008, Assessing the order of magnitude of outcomes in single-arm cohorts through systematic comparison with corresponding cohorts: an example from the AMOS study, BMC Med. Res. Methodol., 8, 11, 10.1186/1471-2288-8-11

Hansen, 2011, The number of persons with alcohol problems in the Danish population, Scand. J. Public Health, 39, 128, 10.1177/1403494810393556

Hausken, 2009, Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors, Eur. J. Clin. Pharmacol., 65, 295, 10.1007/s00228-008-0565-8

Healey, 1998, Economic burden of drug dependency. Social costs incurred by drug users at intake to the National Treatment Outcome Research Study, Br. J. Psychiatry, 173, 160, 10.1192/bjp.173.2.160

Hedner, 2006, Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case–control study, Eur. Respir. J., 27, 564, 10.1183/09031936.06.00042105

Heider, 2009, Direct medical mental health care costs of schizophrenia in France, Germany and the United Kingdom — findings from the European Schizophrenia Cohort (EuroSC), Eur. Psychiatry, 24, 216, 10.1016/j.eurpsy.2008.12.013

Heier, 2009, Prevalence of narcolepsy with cataplexy in Norway, Acta Neurol. Scand., 120, 276, 10.1111/j.1600-0404.2009.01166.x

Helmer, 2006, Dementia in subjects aged 75years or over within the PAQUID cohort: prevalence and burden by severity, Dement. Geriatr. Cogn. Disord., 22, 87, 10.1159/000093459

Hetta, 1999, Evaluation of severe insomnia in the general population—implications for the management of insomnia: insomnia, quality of life and healthcare consumption in Sweden, J. Psychopharmacol., 13, S35, 10.1177/026988119901304S10

Hiller, 2004, High utilizers of medical care: a crucial subgroup among somatizing patients, J. Psychosom. Res., 56, 437, 10.1016/S0022-3999(03)00628-7

Hirst, 2009, Increasing prevalence and incidence of multiple sclerosis in South East Wales, J. Neurol. Neurosurg. Psychiatry, 80, 386, 10.1136/jnnp.2008.144667

Hodgson, 1982, Cost-of-illness methodology: a guide to current practices and procedures, Milbank Mem. Fund Q. Health Soc., 60, 429, 10.2307/3349801

Hoflstein, 2002, Relationship between smoking and sleep apnea in clinic population, Sleep, 25, 519

Hong, 2002, HLA and hypocretin studies in Korean patients with narcolepsy, Sleep, 25, 440, 10.1093/sleep/25.4.432

Hong, 2009, The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study, Prog. Neuropsychopharmacol. Biol. Psychiatry, 33, 835, 10.1016/j.pnpbp.2009.03.034

Hossain, 2002, The prevalence, cost implications, and management of sleep disorders: an overview, Sleep Breath., 6, 85, 10.1055/s-2002-32322

Hublin, 1994, The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort, Ann. Neurol., 35, 709, 10.1002/ana.410350612

Hublin, 1994, Epidemiology of narcolepsy, Sleep, 17, S7, 10.1093/sleep/17.suppl_8.S7

Huisman, 2011, Population based epidemiology of amyotrophic lateral sclerosis using capture–recapture methodology, J. Neurol. Neurosurg. Psychiatry, 10.1136/jnnp.2011.244939

Human Mortality Database, 2010. United Kingdom, Life tables (period 1x1), Total.

Iuliano, 2008, Prevalence and incidence of multiple sclerosis in Salerno (southern Italy) and its province, Eur. J. Neurol., 15, 73, 10.1111/j.1468-1331.2007.02006.x

Jacobi, 2002, Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey, Int. J. Methods Psychiatr. Res., 11, 1, 10.1002/mpr.118

Jacobi, 2004, Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS), Psychol. Med., 34, 597, 10.1017/S0033291703001399

Jacoby, 1998, Uptake and costs of care for epilepsy: findings from a U.K. regional study, Epilepsia, 39, 776, 10.1111/j.1528-1157.1998.tb01164.x

Jansson-Frojmark, 2008, The course of insomnia over one year: a longitudinal study in the general population in Sweden, Sleep, 31, 881, 10.1093/sleep/31.6.881

Järbrink, 2007, The economic consequences of autistic spectrum disorder among children in a Swedish municipality, Autism, 11, 453, 10.1177/1362361307079602

Jarl, 2008, The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002, Eur. J. Health Econ., 9, 351, 10.1007/s10198-007-0082-1

Jennum, 2010, The socio-economical burden of hypersomnia, Acta Neurol. Scand., 121, 265, 10.1111/j.1600-0404.2009.01227.x

Jennum, 2011, Health, social and economical consequences of sleep-disordered breathing: a controlled national study, Thorax, 66, 560, 10.1136/thx.2010.143958

Jennum, 2009, Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing, Eur. Respir. J., 33, 907, 10.1183/09031936.00180108

Jennum, 1993, Snoring, sleep apnoea and cardiovascular risk factors: the MONICA II study, Int. J. Epidemiol., 22, 439, 10.1093/ije/22.3.439

Jennum, 1994, Self-assessed cognitive function in snorers and sleep apneics. An epidemiological study of 1504 females and males aged 30–60years: the Dan-MONICA II study, Eur. Neurol., 34, 204, 10.1159/000117039

Jennum, 2009, The economic consequences of narcolepsy, J. Clin. Sleep Med., 5, 240, 10.5664/jcsm.27493

Joensen, 1986, Prevalence, incidence, and classification of epilepsy in the Faroes, Acta Neurol. Scand., 74, 150, 10.1111/j.1600-0404.1986.tb04642.x

Jonsson, 2002, Revealing the cost of type II diabetes in Europe, Diabetologia, 45, S5, 10.1007/s00125-002-0858-x

Jönsson, 2005, Cost of dementia in Europe, Eur. J. Neurol., 12, 50, 10.1111/j.1468-1331.2005.01190.x

Jönsson, 1999, The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model, Clin. Ther., 21, 1230, 10.1016/S0149-2918(00)80025-9

Jönsson, 2006, Determinants of costs of care for patients with Alzheimer's disease, Int. J. Geriatr. Psychiatry, 21, 449, 10.1002/gps.1489

Kalb, 2002, Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden, Neuroepidemiology, 21, 221, 10.1159/000065639

Keller, 2003, Analysis of direct costs in therapy of Parkinson disease, Nervenarzt, 74, 1105, 10.1007/s00115-003-1582-6

Keränen, 1989, Incidence and prevalence of epilepsy in adults in eastern Finland, Epilepsia, 30, 413, 10.1111/j.1528-1157.1989.tb05320.x

Keränen, 2003, Economic burden and quality of life impairment increase with severity of PD, Parkinsonism Relat. Disord., 9, 163, 10.1016/S1353-8020(02)00097-4

King, 2009, Intellectual disability, 3444

Kleinman, 2003, Costs of bipolar disorder, PharmacoEconomics, 21, 601, 10.2165/00019053-200321090-00001

Knapp, 2002, Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study. European Psychiatric Services: inputs linked to outcome domains and needs, Acta Psychiatr. Scand., 105, 42, 10.1034/j.1600-0447.2002._10310.x

Knapp, 2004, The global costs of schizophrenia, Schizophr. Bull., 30, 279, 10.1093/oxfordjournals.schbul.a007078

Knapp, 2009, Economic cost of autism in the UK, Autism, 13, 317, 10.1177/1362361309104246

Kobelt, 2006, Costs and quality of life for patients with multiple sclerosis in Belgium, Eur. J. Health Econ., 7, S24, 10.1007/s10198-006-0377-7

Kobelt

Kobelt, 2006, Costs and quality of life in multiple sclerosis in The Netherlands, Eur. J. Health Econ., 7, S55, 10.1007/s10198-006-0378-6

Kobelt, 2006, Costs and quality of life of multiple sclerosis in Italy, Eur. J. Health Econ., 7, S45, 10.1007/s10198-006-0385-7

Kobelt, 2006, Costs and quality of life of multiple sclerosis in Germany, Eur. J. Health Econ., 7, S34, 10.1007/s10198-006-0384-8

Kobelt, 2006, Costs and quality of life of multiple sclerosis in Switzerland, Eur. J. Health Econ., 7, S86, 10.1007/s10198-006-0383-9

Kobelt, 2006, Costs and quality of life of multiple sclerosis in Spain, Eur. J. Health Econ., 7, S65, 10.1007/s10198-006-0381-y

Kobelt, 2006, Costs and quality of life of multiple sclerosis in the United Kingdom, Eur. J. Health Econ., 7, S96, 10.1007/s10198-006-0380-z

Kobelt, 2006, Costs and quality of life of multiple sclerosis in Austria, Eur. J. Health Econ., 7, S14, 10.1007/s10198-006-0382-x

Kobelt, 2009, The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions, Mult. Scler., 15, 741, 10.1177/1352458509102771

Kobelt

Kolominsky-Rabas, 2006, Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project, Stroke, 37, 1179, 10.1161/01.STR.0000217450.21310.90

Konnopka, 2007, Direct and indirect costs attributable to alcohol consumption in Germany, PharmacoEconomics, 25, 605, 10.2165/00019053-200725070-00006

Kotsopoulos, 2001, Estimating the costs of epilepsy: an international comparison of epilepsy cost studies, Epilepsia, 42, 634, 10.1046/j.1528-1157.2001.18200.x

Kotsopoulos, 2003, The costs of epilepsy in three different populations of patients with epilepsy, Epilepsy Res., 54, 131, 10.1016/S0920-1211(03)00062-7

Kotsopoulos, 2005, Incidence of epilepsy and predictive factors of epileptic and non-epileptic seizures, Seizure, 14, 175, 10.1016/j.seizure.2005.01.005

Krauth, 2002, How high are the costs of eating disorders – anorexia nervosa and bulimia nervosa – for German society?, Eur. J. Health Econ., 3, 244, 10.1007/s10198-002-0137-2

Kroes, 2001, Child psychiatric diagnoses in a population of Dutch schoolchildren aged 6 to 8years, J. Am. Acad. Child Adolesc. Psychiatry, 40, 1401, 10.1097/00004583-200112000-00010

Kronborg, 1999, The cost of dementia in Denmark: the Odense study, Dement. Geriatr. Cogn. Disord., 10, 295, 10.1159/000017135

Kronholm, 2008, Trends in self-reported sleep duration and insomnia-related symptoms in Finland from 1972 to 2005: a comparative review and re-analysis of Finnish population samples, J. Sleep Res., 17, 54, 10.1111/j.1365-2869.2008.00627.x

Kryger, 2002, Diagnoses received by narcolepsy patients in the year prior to diagnosis by a sleep specialist, Sleep, 25, 36, 10.1093/sleep/25.1.36

Kurz, 2001, Dementia in Belgium: prevalence in aged patients consulting in general practice, Rev. Med. Liege, 56, 835

Laaban, 2009, Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients, Diabetes Metab., 35, 372, 10.1016/j.diabet.2009.03.007

Landgren, 1996, ADHD, DAMP and other neurodevelopmental/psychiatric disorders in 6-year-old children: epidemiology and co-morbidity, Dev. Med. Child Neurol., 38, 891, 10.1111/j.1469-8749.1996.tb15046.x

Larsson, 2006, A population based study of epilepsy in children from a Swedish county, Eur. J. Paediatr. Neurol., 10, 107, 10.1016/j.ejpn.2006.02.005

Latif, 1998, The costs of managing patients with malignant glioma at a neuro-oncology clinic, Br. J. Neurosurg., 12, 118, 10.1080/02688699845230

Latvala, 2009, Prevalence and correlates of alcohol and other substance use disorders in young adulthood: a population-based study, BMC Psychiatry, 9, 73, 10.1186/1471-244X-9-73

Lauber, 2005, Family burden during exacerbation of schizophrenia: quantification and determinants of additional costs, Int. J. Soc. Psychiatry, 51, 259, 10.1177/0020764005057376

LeBlanc, 2009, Incidence and risk factors of insomnia in a population-based sample, Sleep, 32, 1027, 10.1093/sleep/32.8.1027

Leger, 2005, An international survey of insomnia: under-recognition and under-treatment of a polysymptomatic condition, Curr. Med. Res. Opin., 21, 1785, 10.1185/030079905X65637

Leger, 1999, The direct costs of insomnia in France, Sleep, 22, S394

Leger, 2000, Prevalence of insomnia in a survey of 12,778 adults in France, J. Sleep Res., 9, 35, 10.1046/j.1365-2869.2000.00178.x

Leger, 2006, Professional correlates of insomnia, Sleep, 29, 171

LePen, 1999, Cost of illness and disease severity in a cohort of French patients with Parkinson's disease, PharmacoEconomics, 16, 59, 10.2165/00019053-199916010-00006

Lépine, 2002, The epidemiology of anxiety disorders: prevalence and societal costs, J. Clin. Psychiatry, 63, 4

Li, 2008, Socioeconomic status and occupation as risk factors for obstructive sleep apnea in Sweden: a population-based study, Sleep Med., 9, 129, 10.1016/j.sleep.2007.02.003

Lindberg, 2007, Snoring and daytime sleepiness as risk factors for hypertension and diabetes in women—a population-based study, Respir. Med., 101, 1283, 10.1016/j.rmed.2006.10.015

Linde, M., Gustavsson, A., Stovner, L.J., Barré, J., Katsarava, Z., Lainez, J,M., Lampl, C., Lantéri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Steiner, T.J., Tassorelli, C., Andrée, C., 2011. The cost of headache disorders in Europe — the Eurolight project. Manuscript.

Lindgren, 2005, Cost of Parkinson's disease in Europe, Eur. J. Neurol., 12, 68, 10.1111/j.1468-1331.2005.01197.x

Lindström, 2007, Costs of schizophrenia during 5years, Acta Psychiatr. Scand. Suppl., 33, 10.1111/j.1600-0447.2007.01086.x

Linehan, 2010, Examining the prevalence of epilepsy and delivery of epilepsy care in Ireland, Epilepsia, 51, 845, 10.1111/j.1528-1167.2009.02417.x

Livingston, 2004, A dependency model for patients with Alzheimer's disease: its validation and relationship to the costs of care—the LASER-AD study, Curr. Med. Res. Opin., 20, 1007, 10.1185/030079904125003980

Löfgren, 2009, Epilepsy in the northern Finland birth cohort 1966 with special reference to fertility, Epilepsy Behav., 14, 102, 10.1016/j.yebeh.2008.08.007

Lopez-Bastida, 2006, Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain, Neurology, 67, 2186, 10.1212/01.wnl.0000249311.80411.93

Loredo, 2010, Sleep health in U.S. Hispanic population, Sleep, 33, 962, 10.1093/sleep/33.7.962

Louis, 2007, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol., 114, 97, 10.1007/s00401-007-0243-4

Luengo, 2001, Prevalence of epilepsy in northeast Madrid, J. Neurol., 248, 762, 10.1007/s004150170091

Luengo-Fernandez, 2009, Costs of stroke using patient-level data: a critical review of the literature, Stroke, 40, e18, 10.1161/STROKEAHA.108.529776

Mahdi-Rogers, 2008, Epidemiology and treatment of chronic inflammatory neuropathies in South East England, Eur. J. Neurol., 15

Mahdi-Rogers, 2008, Prevalence and morbidity of chronic inflammatory neuropathies in South East England, J. Peripher. Nerv. Syst., 13

Mahdi-Rogers, 2009, Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy, J. Peripher. Nerv. Syst., 14, 118, 10.1111/j.1529-8027.2009.00221.x

Mahler, 2008, A cost analysis of the first year after stroke — early triage and inpatient rehabilitation may reduce long term costs, Swiss. Med. Wkly., 138, 459

Malcienë, L., Pauza, V., 2003. Iðsëtinës sklerozës klinikos ir epidemiologijos ypatumai Kauno mieste. 218, 66–69.

Mangalore, 2007, Cost of schizophrenia in England, J. Ment. Health Policy Econ., 10, 23

Maremmani, 1991, Descriptive epidemiologic study of epilepsy syndromes in a district of northwest Tuscany, Italy, Epilepsia, 32, 294, 10.1111/j.1528-1157.1991.tb04654.x

Martikainen, 2003, The impact of somatic health problems on insomnia in middle age, Sleep Med., 4, 201, 10.1016/S1389-9457(02)00194-6

Martinez-Leal, 2011, The impact of living arrangements and deinstitutionalisation in the health status of persons with intellectual disability in Europe, J. Intellect. Disabil. Res., 55, 858, 10.1111/j.1365-2788.2011.01439.x

Maulik, 2011, Prevalence of intellectual disability: a meta-analysis of population-based studies, Res. Dev. Disabil., 32, 419, 10.1016/j.ridd.2010.12.018

Maurel, 2001, Social and economic cost of l-dopa-induced dyskinesias in patients with Parkinson's disease, Rev. Neurol. (Paris), 157, 507

McCracken, 2006, Health service use by adults with depression: community survey in five European countries. Evidence from the ODIN study, Br. J. Psychiatry, 189, 161, 10.1192/bjp.bp.105.015081

McCrone, 2005, The Maudsley long-term follow-up of child and adolescent depression. Predicting costs in adulthood, Eur. Child Adolesc. Psychiatry, 14, 407, 10.1007/s00787-005-0491-6

McCrone, 2007, Predicting the cost of Parkinson's disease, Mov. Disord., 22, 804, 10.1002/mds.21360

McCrone, 2008, Multiple sclerosis in the UK: service use, costs, quality of life and disability, PharmacoEconomics, 26, 847, 10.2165/00019053-200826100-00005

McEvoy, 2007, The costs of schizophrenia, J. Clin. Psychiatry, 68, 4

McGrogan, 2009, The epidemiology of Guillain–Barre syndrome worldwide. A systematic literature review, Neuroepidemiology, 32, 150, 10.1159/000184748

McNicholas, 1986, Sleep apnoea in the British Isles, Lancet, 2, 295, 10.1016/S0140-6736(86)92123-9

Meerding, 2006, Incidence and costs of injuries in The Netherlands, Eur. J. Public Health, 16, 272, 10.1093/eurpub/ckl006

Mesterton, 2010, Cross sectional observational study on the societal costs of Alzheimer's disease, Curr. Alzheimer Res., 7, 358, 10.2174/156720510791162430

Morgante, 1992, Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) Group, Neurology, 42, 1901, 10.1212/WNL.42.10.1901

Morris, 2008, Determinants of hospital costs associated with traumatic brain injury in England and Wales, Anaesthesia, 63, 499, 10.1111/j.1365-2044.2007.05432.x

Neven, 1998, The prevalence of clinically significant sleep apnoea syndrome in The Netherlands, Thorax, 53, 638, 10.1136/thx.53.8.638

Norlund, 2006, Immediate computed tomography or admission for observation after mild head injury: cost comparison in randomised controlled trial, BMJ, 333, 469, 10.1136/bmj.38918.659120.4F

Norwood, 2009, Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population, Brain, 132, 3175, 10.1093/brain/awp236

Nutt, 2011, ECNP Summit on the future of CNS drug research in Europe 2011: report prepared for ECNP by David Nutt and Guy Goodwin, Eur. Neuropsychopharmacol., 21, 495, 10.1016/j.euroneuro.2011.05.004

OECD statistics

Office of National Statistics (ONC)

Ohayon, 2002, Insomnia and global sleep dissatisfaction in Finland, J. Sleep Res., 11, 339, 10.1046/j.1365-2869.2002.00317.x

Ohayon, 1997, Snoring and breathing pauses during sleep: telephone interview survey of a United Kingdom population sample, BMJ, 314, 860, 10.1136/bmj.314.7084.860

Ohayon, 2002, Prevalence of narcolepsy symptomatology and diagnosis in the European general population, Neurology, 58, 1826, 10.1212/WNL.58.12.1826

Olafsson, 1999, Prevalence of epilepsy in rural Iceland: a population-based study, Epilepsia, 40, 1529, 10.1111/j.1528-1157.1999.tb02036.x

Olafsson, 2005, Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study, Lancet Neurol., 4, 627, 10.1016/S1474-4422(05)70172-1

Olesen, 2003, The burden of brain diseases in Europe, Eur. J. Neurol., 10, 471, 10.1046/j.1468-1331.2003.00682.x

Olie, 2002, Manic episodes: the direct cost of a three-month period following hospitalisation, Eur. Psychiatry, 17, 278, 10.1016/S0924-9338(02)00680-6

Oliva-Moreno, 2006, The costs of schizophrenia in Spain, Eur. J. Health Econ., 7, 182, 10.1007/s10198-006-0350-5

Olivares, 2008, Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia: a 12- and 24-month follow-up from the e-STAR database in Spain, Appl. Health Econ. Health Policy, 6, 41, 10.2165/00148365-200806010-00004

Oöpik, 2003, A population based epidemiological study on myasthenia gravis in Estonia, J. Neurol. Neurosurg. Psychiatry, 74, 1638, 10.1136/jnnp.74.12.1638

Orlewska, 2005, A prospective study of the financial costs of multiple sclerosis at different stages of the disease, Eur. J. Neurol., 12, 31, 10.1111/j.1468-1331.2004.00950.x

Osby, 2009, Psychiatric admissions and hospitalization costs in bipolar disorder in Sweden, J. Affect. Disord., 115, 315, 10.1016/j.jad.2008.09.011

O'Shea

O'Shea, 2000, The economic and social cost of dementia in Ireland, Int. J. Geriatr. Psychiatry, 15, 208, 10.1002/(SICI)1099-1166(200003)15:3<208::AID-GPS95>3.0.CO;2-X

Ott, 1995, Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study, BMJ, 310, 970, 10.1136/bmj.310.6985.970

Öun, 2003, Prevalence of adult epilepsy in Estonia, Epilepsy Res., 52, 233, 10.1016/S0920-1211(02)00234-6

Packer, 2008, Central nervous system tumors, Pediatr. Clin. North Am., 55, 121, 10.1016/j.pcl.2007.10.010

Pallesen, 2001, Prevalence of insomnia in the adult Norwegian population, Sleep, 24, 771

Pallesen, 2007, Prevalence and risk factors of subjective sleepiness in the general adult population, Sleep, 30, 619, 10.1093/sleep/30.5.619

Papathanasopoulos, 2008, Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey, Neuroepidemiology, 30, 167, 10.1159/000122334

Partinen, 1995, Epidemiology of obstructive sleep apnea syndrome, Curr. Opin. Pulm. Med., 1, 482, 10.1097/00063198-199511000-00009

Partinen, 1994, Twin studies in narcolepsy, Sleep, 17, S13, 10.1093/sleep/17.suppl_8.S13

Patel, 2002, The economic consequences of social phobia, J. Affect. Disord., 68, 221, 10.1016/S0165-0327(00)00323-2

Pechevis, 2005, Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study, Eur. J. Neurol., 12, 956, 10.1111/j.1468-1331.2005.01096.x

Pelham, 2007, The economic impact of attention-deficit/hyperactivity disorder in children and adolescents, J. Pediatr. Psychol., 32, 711, 10.1093/jpepsy/jsm022

Peter, 1985, Prevalence of sleep apnea in healthy industrial workers, Klin. Wochenschr., 63, 807, 10.1007/BF01732285

Peterlin, 2006, Region with persistent high frequency of multiple sclerosis in Croatia and Slovenia, J. Neurol. Sci., 247, 169, 10.1016/j.jns.2006.04.002

Pharmacy Sales Prices (AUP)

Picot, 2008, The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country, Epilepsia, 49, 1230, 10.1111/j.1528-1167.2008.01579.x

Polder, 2002, Healthcare costs of intellectual disability in the Netherlands: a cost-of-illness perspective, J. Intellect. Disabil. Res., 46, 168, 10.1046/j.1365-2788.2002.00384.x

Polinder, 2005, Cost estimation of injury-related hospital admissions in 10 European countries, J. Trauma, 59, 1283, 10.1097/01.ta.0000195998.11304.5b

Poulas, 2001, Epidemiology of seropositive myasthenia gravis in Greece, J. Neurol. Neurosurg. Psychiatry, 71, 352, 10.1136/jnnp.71.3.352

Pouratian, 2010, Management of low-grade glioma, Curr. Neurol. Neurosci. Rep., 10, 224, 10.1007/s11910-010-0105-7

Pradalier, 2004, Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study, PharmacoEconomics, 22, 985, 10.2165/00019053-200422150-00003

Priebe, 2009, Consequences of untreated posttraumatic stress disorder following war in former Yugoslavia: morbidity, subjective quality of life, and care costs, Croat. Med. J., 50, 465, 10.3325/cmj.2009.50.465

Priebe, 2010, Treatment outcomes and costs at specialized centers for the treatment of PTSD after the war in former Yugoslavia, Psychiatr. Serv., 61, 598, 10.1176/appi.ps.61.6.598

PSSRU, 2011, 41

Puura, 1998, Psychiatric disturbances among prepubertal children in southern Finland, Soc. Psychiatry Psychiatr. Epidemiol., 33, 310, 10.1007/s001270050060

Rahkonen, 2003, Dementia with Lewy bodies according to the consensus criteria in a general population aged 75years or older, J. Neurol. Neurosurg. Psychiatry, 74, 720, 10.1136/jnnp.74.6.720

Ranzato, 2003, Increasing frequency of multiple sclerosis in Padova, Italy: a 30year epidemiological survey, Mult. Scler., 9, 387, 10.1191/1352458503ms920oa

Reese, 2010, Parkinson's disease: cost-of-illness in an outpatient cohort, Gesundheitswesen, 73, 22, 10.1055/s-0030-1247571

Rehm, 2005, Alcohol use disorders in EU countries and Norway: an overview of the epidemiology, Eur. Neuropsychopharmacol., 15, 377, 10.1016/j.euroneuro.2005.04.005

Reid, 2002, Frequent attenders with medically unexplained symptoms: service use and costs in secondary care, Br. J. Psychiatry, 180, 248, 10.1192/bjp.180.3.248

Rickels, 2010, Head injury in Germany: a population-based prospective study on epidemiology, causes, treatment and outcome of all degrees of head-injury severity in two distinct areas, Brain Inj., 24, 1491, 10.3109/02699052.2010.498006

Riedel-Heller, 2001, Prevalence of dementia according to DSM-III-R and ICD-10: results of the Leipzig Longitudinal Study of the Aged (LEILA75+) part 1, Br. J. Psychiatry, 179, 250, 10.1192/bjp.179.3.250

Rigaud, 2003, Patients with Alzheimer's disease living at home in France: costs and consequences of the disease, J. Geriatr. Psychiatry Neurol., 16, 140, 10.1177/0891988703252558

Rocca, 2001, Door-to-door prevalence survey of epilepsy in three Sicilian municipalities, Neuroepidemiology, 20, 237, 10.1159/000054796

Romeo, 2006, Economic cost of severe antisocial behaviour in children—and who pays it, Br. J. Psychiatry, 188, 547, 10.1192/bjp.bp.104.007625

Rossi, 2006, Variable costs of ICU patients: a multicenter prospective study, Intensive Care Med., 32, 545, 10.1007/s00134-006-0080-2

Roy, 2010, Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization, Sleep Med., 11, 462, 10.1016/j.sleep.2009.09.012

Russo, 2004, Cost-analysis of relapsing–remitting multiple sclerosis in Italy after the introduction of new disease-modifying agents, Clin. Drug Investig., 24, 409, 10.2165/00044011-200424070-00004

Saar, 2009, The social costs of alcohol misuse in Estonia, Eur. Addict. Res., 15, 56, 10.1159/000173010

Salawu, 2009, Overview of somatization-diagnosis and management, Niger. J. Med., 18, 349

Salize, 2004, Cost of care for depressive disorders in primary and specialized care in Germany, Psychiatr. Prax., 31, 147

Salize, 2009, Cost of treatment of schizophrenia in six European countries, Schizophr. Res., 111, 70, 10.1016/j.schres.2009.03.027

Salvador-Carulla, 2008, ‘Mental retardation’ or ‘intellectual disability’: time for a conceptual change, Psychopathology, 41, 10, 10.1159/000109950

Salvador-Carulla, 1995, Costs and offset effect in panic disorders, Br. J. Psychiatry Suppl., 23, 10.1192/S0007125000293367

Salvador-Carulla, 2011, Costs of depression in Catalonia (Spain), J. Affect. Disord., 132, 130, 10.1016/j.jad.2011.02.019

Sancho, 2008, Health and non-health care resources use in the management of adult outpatients with drug-resistant epilepsy in Spain: a cost-of-illness study (LINCE study), Epilepsy Res., 81, 176, 10.1016/j.eplepsyres.2008.05.008

Sangrador, 1991, Study of the prevalence of epilepsy among school children in Valladolid, Spain, Epilepsia, 32, 791, 10.1111/j.1528-1157.1991.tb05535.x

Sasai, 2010, Effects of insomnia and sleep medication on health-related quality of life, Sleep Med., 11, 452, 10.1016/j.sleep.2009.09.011

Schenk, 2010, Dtsch. Med. Wochenschr., 135, 24, 10.1055/s-0030-1247687

Schepelmann, 2010, Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy, J. Neurol., 257, 15, 10.1007/s00415-009-5256-6

Schrag, 2000, Cross sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London, BMJ, 321, 21, 10.1136/bmj.321.7252.21

Schulenberg, 1998, Cost of treatment and cost of care for Alzheimer's disease in Germany, 217

Scuvee-Moreau, 2002, The economic impact of dementia in Belgium: results of the National Dementia Economic Study (NADES), Acta Neurol. Belg., 102, 104

Sicras-Mainar, 2010, Impact of morbidity, resource use and costs on maintenance of remission of major depression in Spain: a longitudinal study in a population setting, Gac. Sanit., 24, 13, 10.1016/j.gaceta.2009.05.012

Sidenvall, 1996, Prevalence and characteristics of epilepsy in children in northern Sweden, Seizure, 5, 139, 10.1016/S1059-1311(96)80108-7

Silber, 2002, The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study, Sleep, 25, 197, 10.1093/sleep/25.2.197

Sillanpää, 1973, Medico-social prognosis of children with epilepsy. Epidemiological study and analysis of 245 patients, Acta Paediatr. Scand. Suppl., 237, 3

Sivertsen, 2006, The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study, Am. J. Epidemiol., 163, 1018, 10.1093/aje/kwj145

Sivertsen, 2009, Insomnia symptoms and use of health care services and medications: the HUNT-2 study, Behav. Sleep Med., 7, 210, 10.1080/15402000903190199

Sivertsen, 2009, The epidemiology of insomnia: associations with physical and mental health. The HUNT-2 study, J. Psychosom. Res., 67, 109, 10.1016/j.jpsychores.2009.05.001

Sivertsen, 2010, Sleep problems in general practice: a national survey of assessment and treatment routines of general practitioners in Norway, J. Sleep Res., 19, 36, 10.1111/j.1365-2869.2009.00769.x

Smestad, 2008, Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway, J. Neurol., 255, 49, 10.1007/s00415-007-0659-8

Smit, 2006, Costs of nine common mental disorders: implications for curative and preventive psychiatry, J. Ment. Health Policy Econ., 9, 193

Smith, 2010, Cost of Stroke in Ireland: Estimating the Annual Economic Cost of Stroke and TIA in Ireland

Sobocki, 2006, Resource allocation to brain research in Europe (RABRE), Eur. J. Neurosci., 24, 2691, 10.1111/j.1460-9568.2006.05116.x

Soeteman, 2008, The economic burden of personality disorders in mental health care, J. Clin. Psychiatry, 69, 259, 10.4088/JCP.v69n0212

Solaro, 2005, The prevalence of multiple sclerosis in the north-west Italian province of Genoa, J. Neurol., 252, 436, 10.1007/s00415-005-0670-x

Souetre, 1994, Cost of anxiety disorders: impact of comorbidity, J. Psychosom. Res., 38, 151, 10.1016/0022-3999(94)90145-7

Souetre, 1995, Economic analysis of Alzheimer's disease in outpatients: impact of symptom severity, Int. Psychogeriatr., 7, 115, 10.1017/S1041610295001906

Spottke, 2005, Cost of illness and its predictors for Parkinson's disease in Germany, PharmacoEconomics, 23, 817, 10.2165/00019053-200523080-00007

Steinhausen, 1998, Prevalence of child and adolescent psychiatric disorders: the Zurich Epidemiological Study, Acta Psychiatr. Scand., 98, 262, 10.1111/j.1600-0447.1998.tb10082.x

Stiller, 1992, Brain and spinal tumours in children aged under two years: incidence and survival in Britain, 1971–85, Br. J. Cancer Suppl., 18, S50

Stovner, 2010, Prevalence of headache in Europe: a review for the Eurolight project, J. Headache Pain, 11, 289, 10.1007/s10194-010-0217-0

Stranjalis, 2008, Outcome in 1000 head injury hospital admissions: the Athens head trauma registry, J. Trauma, 65, 789, 10.1097/TA.0b013e3181469e26

Stranjalis, 2009, Low occurrence of epileptic seizures and epilepsy in a defined area of Northwest Greece, Seizure, 18, 206, 10.1016/j.seizure.2008.09.007

Strassels, 2009, Economic burden of prescription opioid misuse and abuse, J. Manag. Care Pharm., 15, 556, 10.18553/jmcp.2009.15.7.556

Struijs, 2006, Future costs of stroke in the Netherlands: the impact of stroke services, Int. J. Technol. Assess. Health Care, 22, 518, 10.1017/S0266462306051464

Stupp, 2005, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N. Engl. J. Med., 352, 987, 10.1056/NEJMoa043330

Sumelahti, 2001, Increasing prevalence of multiple sclerosis in Finland, Acta Neurol. Scand., 103, 153, 10.1034/j.1600-0404.2001.103003153.x

Sveen, 2006, High prevalence and phenotype–genotype correlations of limb girdle muscular dystrophy type 2I in Denmark, Ann. Neurol., 59, 808, 10.1002/ana.20824

Svendsen, 2007, Age-specific prevalence of epilepsy in Oppland County, Norway, Acta Neurol. Scand., 116, 307, 10.1111/j.1600-0404.2007.00909.x

Swingler, 1994, The cost of epilepsy in patients attending a specialist epilepsy service, Seizure, 3, 115, 10.1016/S1059-1311(05)80201-8

Tafalla, 2010, Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain, BMC Psychiatry, 10, 31, 10.1186/1471-244X-10-31

Tagliaferri, 2006, A systematic review of brain injury epidemiology in Europe, Acta Neurochir. (Wien.), 148, 255, 10.1007/s00701-005-0651-y

Taylor, 1991

Teculescu, 2001, Prevalence of habitual snoring in a sample of French males. Role of “minor” nose–throat abnormalities, Respiration, 68, 365, 10.1159/000050528

Tetto, 2002, The costs of epilepsy in Italy: a prospective cost-of-illness study in referral patients with disease of different severity, Epilepsy Res., 48, 207, 10.1016/S0920-1211(02)00013-X

The Health and Social Care Information Centre

Thomas, 2003, Cost of depression among adults in England in 2000, Br. J. Psychiatry, 183, 514, 10.1192/bjp.183.6.514

Tidman, 2003, Epilepsy in mainstream and special educational primary school settings, Seizure, 12, 47, 10.1016/S1059131102001711

Tison, 1994, Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France, Acta Neurol. Scand., 90, 111, 10.1111/j.1600-0404.1994.tb02689.x

Tognoni, 2005, From mild cognitive impairment to dementia: a prevalence study in a district of Tuscany, Italy, Acta Neurol. Scand., 112, 65, 10.1111/j.1600-0404.2005.00444.x

Trabucchi, 1999, An economic perspective on Alzheimer's disease, J. Geriatr. Psychiatry Neurol., 12, 29, 10.1177/089198879901200107

Troxel, 2010, Marital/cohabitation status and history in relation to sleep in midlife women, Sleep, 33, 973, 10.1093/sleep/33.7.973

Truelsen, 2006, Stroke incidence and prevalence in Europe: a review of available data, Eur. J. Neurol., 13, 581, 10.1111/j.1468-1331.2006.01138.x

Tsolaki, 1999, Prevalence and incidence of Alzheimer disease and other dementing disorders in Pylea, Greece, Am. J. Alzheimers Dis., 14, 138, 10.1177/153331759901400308

Uhl, 2009

Ursin, 2009, Sleep duration and sleep-related problems in different occupations in the Hordaland Health Study, Scand. J. Work Environ. Health, 35, 193, 10.5271/sjweh.1325

van Asselt, 2007, The cost of borderline personality disorder: societal cost of illness in BPD-patients, Eur. Psychiatry, 22, 354, 10.1016/j.eurpsy.2007.04.001

van Hout, 1997, Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom, Epilepsia, 38, 1221, 10.1111/j.1528-1157.1997.tb01220.x

van Mill, 2010, Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders, J. Clin. Psychiatry, 71, 239, 10.4088/JCP.09m05218gry

Verhulst, 1997, The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents, Arch. Gen. Psychiatry, 54, 329, 10.1001/archpsyc.1997.01830160049008

Vgontzas, 2009, Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study, Diabetes Care, 32, 1980, 10.2337/dc09-0284

von Campenhausen, 2009, Cost of illness and health service patterns in Morbus Parkinson in Austria, Wien. Klin. Wochenschr., 121, 574, 10.1007/s00508-009-1223-6

Waage, 2009, Shift work disorder among oil rig workers in the North Sea, Sleep, 32, 558, 10.1093/sleep/32.4.558

Waaler, 2000, Prevalence, classification, and severity of epilepsy in children in western Norway, Epilepsia, 41, 802, 10.1111/j.1528-1157.2000.tb00246.x

Wasserfallen, 2005, Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death, Neuro. Oncol., 7, 189, 10.1215/S1152851704000687

Wellis, 2003, Direct costs of microsurgical management of radiosurgically amenable intracranial pathology in Germany: an analysis of meningiomas, acoustic neuromas, metastases and arteriovenous malformations of less than 3cm in diameter, Acta Neurochir. (Wien.), 145, 249, 10.1007/s00701-003-0007-4

Whiteneck, 2004, Population-based estimates of outcomes after hospitalization for traumatic brain injury in Colorado, Arch. Phys. Med. Rehabil., 85, S73, 10.1016/j.apmr.2003.08.107

WHO Europe

Wilking, 2005

Wilking

Wilms, 2004, Illness related costs for spouses of patients suffering from a mental illness: results of a study with repeated measurements, Psychiatr. Prax., 31, 177

Wimo, 2010, The economic impact of dementia in Europe in 2008—cost estimates from the Eurocode project, Int. J. Geriatr. Psychiatry

Wing, 2002, The prevalence of narcolepsy among Chinese in Hong Kong, Ann. Neurol., 51, 578, 10.1002/ana.10162

Winter, 2010, Costs of Parkinson's disease in eastern Europe: a Czech cohort study, Parkinsonism Relat. Disord., 16, 51, 10.1016/j.parkreldis.2009.07.005

Winter, 2010, Costs of Parkinson's disease and antiparkinsonian pharmacotherapy: an Italian cohort study, Neurodegener. Dis., 7, 365, 10.1159/000302644

Wittchen, 2005, Size and burden of mental disorders in Europe-a critical review and appraisal of 27 studies, Eur Neuropsychopharmacol., 15, 357, 10.1016/j.euroneuro.2005.04.012

Wittchen, 2010, The timing of depression: an epidemiological perspective, Medicographia, 32, 155-125

Wittchen, 2008, What are the high risk periods for incident substance use and transitions to abuse and dependence? Implications for early intervention and prevention, Int. J. Methods Psychiatr. Res., 17, S16, 10.1002/mpr.254

Wittchen, 2009, The structure of mental disorders re-examined: is it developmentally stable and robust against additions?, Int. J. Methods Psychiatr. Res., 18, 189, 10.1002/mpr.298

Wittchen, 2009, Posttraumatic stress disorder: diagnostic and epidemiological perspectives, CNS Spectr., 14, 5

Wittchen, 2011, The size and burden of mental disorders and other disorders of the brain in Europe 2010, Eur. Neuropsychopharmacol., 21, 655, 10.1016/j.euroneuro.2011.07.018

Wolstenholme, 2002, Estimating the relationship between disease progression and cost of care in dementia, Br. J. Psychiatry, 181, 36, 10.1192/bjp.181.1.36

Wrensch, 2002, Epidemiology of primary brain tumors: current concepts and review of the literature, Neuro. Oncol., 4, 278, 10.1093/neuonc/4.4.278

Young, 1996, Sleep-disordered breathing in older adults: is it a condition distinct from that in middle-aged adults?, Sleep, 19, 529, 10.1093/sleep/19.7.529

Young, 1993, The occurrence of sleep-disordered breathing among middle-aged adults, N. Engl. J. Med., 328, 1230, 10.1056/NEJM199304293281704

Young, 1997, Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults, Sleep, 20, 608, 10.1093/sleep/20.8.608

Young, 1997, Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women, Sleep, 20, 705, 10.1093/sleep/20.9.705

Young, 1997, Population-based study of sleep-disordered breathing as a risk factor for hypertension, Arch. Intern. Med., 157, 1746, 10.1001/archinte.157.15.1746

Young, 2002, Epidemiology of obstructive sleep apnea: a population health perspective, Am. J. Respir. Crit. Care Med., 165, 1217, 10.1164/rccm.2109080

Zaloshnja, 2008, Prevalence of long-term disability from traumatic brain injury in the civilian population of the United States, 2005, J. Head Trauma Rehabil., 23, 394, 10.1097/01.HTR.0000341435.52004.ac

Zambori, 2002, Cost–outcome of anxiety treatment intervention in primary care in Hungary, J. Ment. Health Policy Econ., 5, 115

Zielinski, 1974, Epilepsy and mortality rate and cause of death, Epilepsia, 15, 191, 10.1111/j.1528-1157.1974.tb04941.x